RxDoctor Payments Data

IXIARO: cost and payments to doctors

What Medicare Part D paid pharmacies for IXIARO, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 20192025.

What IXIARO costs under Medicare Part D

$316paid to pharmacies per 30-day fill, on average

This is what Part D plans and patients paid pharmacies — not what you would pay, and not money the prescriber received. Your own cost depends on your plan and where you are in your benefit year. It excludes commercial insurance, Medicaid and Part B, and it is before the manufacturer rebates CMS does not publish.

Per 30-day fill
$316

The comparable unit

12 fills
$3,790

A year of therapy, if taken monthly

Prescribers
42

With 11+ claims; CMS suppresses fewer

Active ingredient
Japanese Encephalitis Vacc/Pf
Claims (published)
1,438
30-day fills
1,438
Total paid to pharmacies
$454,169

Most prescribed by family practice, nurse practitioner, emergency medicine.

Source: CMS Medicare Part D Prescribers — by Provider and Drug. Totals cover rows CMS published; prescriber-drug pairs with fewer than 11 claims are suppressed and are not counted here.

Was your doctor paid by Valneva USA, Inc.?

Valneva USA, Inc. reported the most payments naming IXIARO. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$220K
Providers
28
Transactions
104
Average per transaction
$2,113

The per-transaction average — $2,113 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 28 providers the average total is $7,849, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Valneva USA, Inc.$218,71799.5%
Valneva Austria GmbH$1,0500.5%

Other products from Valneva USA, Inc.

The company that reported the most payments naming IXIARO also reports against these.

← All drugs & devices